OnKure Therapeutics Stock (NASDAQ:OKUR)
Previous Close
$5.19
52W Range
$4.58 - $20.00
50D Avg
$11.10
200D Avg
$14.92
Market Cap
$63.26M
Avg Vol (3M)
$113.58K
Beta
-
Div Yield
-
OKUR Company Profile
OnKure, Inc. engages in the discovery and development of oncology-precision medicines for the treatment of cancer. The company focuses on developing selective inhibitors of histone deacetylases. Its portfolio includes OKI-179, an inhibitor for the treatment of both hematological and solid tumors. The company was incorporated in 2011 and is based in Boulder, Colorado.